Wed, Sep 22 | Zoom Call

Clenbuterol for ALS: Findings From an Open Label Trial

Registration is Closed
Clenbuterol for ALS: Findings From an Open Label Trial

Time & Location

Sep 22, 4:00 PM
Zoom Call

About the Event

We are excited to host EverythingALS Community Event: Clenbuterol for ALS: Findings From an Open Label Trial

We invite you to join us and other people with ALS and families to engage in a positive setting of collaboration and community.

The meeting will be on Wednesday, September 22nd 2021 at 4:00 pm PT

-5:00pm Mountain Time

-6:00pm Central Time

-7:00pm Eastern Time

The meeting will be approximately 45-60mins long followed by an open forum.

Once you RSVP the Zoom details with password will be sent via email. Watch out for the email. If you have any questions please email us at

Our speaker Richard Bedlack M.D., Ph.D. is currently a Professor of Neurology at Duke University, and Director of the Duke ALS Clinic.   He has won awards for teaching and for patient care, including: best neurology teacher at Duke; Health Care Hero; Strength, Hope, and Caring Award; America’s Best Doctors; the American Academy of Neurology's Kenneth M. Viste, Jr., MD, Patient Advocate of the Year Award, and the ALS Association's Rasmussen Award for ALS Patient Advocate of the Year. Dr. Bedkack has also received research grants, participated in clinical trials, and published more than 130 articles. He currently leads the international ALSUntangled program, which utilizes social networking to investigate alternative and off-label treatment options for patients with ALS, and the ALS Reversals program which seeks to verify and understand cases of recovery from ALS in hopes of making them happen more often.

​We look forward to seeing you at the event!

Share This Event